D. Davidson Easson Jr, ScD

Director, Bioengineering Institute ad interim
Director, Life Sciences & Bioengineering Center

Phone: +1-508-831-4993
Fax: +1-508-831-5808
B.S., University of South Carolina; Sc.D. MIT

David Easson has over 20 years experience in the biotech industry in both private and public companies. Prior to joining WPI, he was Director, BioProcess Division at IMPACT Technology Development, a contract development organization in Lincoln and Devens, MA. Prior to that he was VP Manufacturing and Process Development at Epic Therapeutics, Inc. (Norwood, MA), a private drug delivery company which was acquired by Baxter Healthcare Corporation. Dr. Easson was also General Manager with Collaborative BioAlliance at their Smithfield, RI contract biopharmaceutical manufacturing facility. Prior to that, Dr. Easson was co-founder and Chief Operating Officer of Alpha-Beta Technology Inc. (Worcester, MA), a public company involved in the development and manufacturing of yeast derived biopharmaceuticals. He has served on the boards of the UMass Memorial Foundation, the Worcester Business Development Corporation and the Juvenile Diabetes Research Foundation (JDRF) Bay State Chapter. He also served as a research grant review committee member for JDRF International. In 1993, Dr. Easson was a finalist for Ernst & Young’s New England Region Entrepreneur of the Year Award. He received the Mary Ann Kugel award from JDRF in 2001. He also received a 2006 Baxter Outstanding Technical Achievement award. Dr. Easson has a B.S. in chemical engineering from the University of South Carolina and a Sc.D. in biochemical engineering from MIT.

Maintained by webmaster@wpi.edu
Last modified: September 20, 2011 11:15:24